C. difficile Colitis

An urgent public health threat

500,000 Americans will get antibiotic-induced C. difficile colitis this year and 30,000 will die. The infection is hard to cure and highly recurrent.

Clostridioides difficile is an anaerobic bacteria. Not only does it thrive without oxygen, but oxygen is actually toxic to it. When exposed to oxygen it dies, leaving behind spores which can be thought of as really tiny hard-shelled nuts. They are dormant and very resilient.

These spores get into our digestive tract when we swallow contaminated food or air. When they reach the colon which has little oxygen, they germinate which is analogous to a seed nut sprouting.

Under normal circumstances our colon’s microbiome, a community of micro-organisms (bacteria, fungi, viruses, phages), crowds out the germinated C. difficile cells, preventing them from multiplying sufficiently to cause disease. Think of this like throwing out walnuts onto a messy overgrown lawn of grass and weeds. You probably won’t get any walnut trees.

Antibiotics are the foundation of modern medicine. They are used to cure otherwise potentially fatal bacterial infections of the bladder, kidney, skin, lungs, abdomen, and blood. They allow us to safely perform complex surgeries, organ transplants, chemotherapy for cancer, and treat autoimmune diseases where the body's immune system is compromised.

Unfortunately, antibiotics are also toxic to the bacteria in our colon, disrupting our microbiome, decreasing its ability to protect us from a C. difficile infection. This is analogous to plowing the aforementioned lawn, which kills some of the weeds and grass and loosens the soil so that the walnuts sprout and take root to make trees.

Once an infection takes root C. difficile produces toxins and causes inflammation that result in diarrhea, pain, dehydration, kidney failure, toxic megacolon, bowel perforation, colectomy, sepsis and death. Anybody can get C. difficile colitis, though some are at more risk than others. A single dose of any antibiotic can cause C. difficile colitis, though some antibiotics are riskier than others.

The CDC considers C. difficile an urgent public health threat.

- A half million Americans will get antibiotic-induced C. difficile colitis this year and 30,000 will die.

- There is no prevention. Big pharma has tried and failed to develop a vaccine. The infection is hard to cure and highly recurrent.

- Forty billion daily doses of antibiotics are prescribed each year globally. Two hundred seventy million antibiotic prescriptions are issued in the USA each year. Eighteen million hospitalized Americans will receive antibiotic therapy this year. These people need protection.

If you concerned about your personal diagnosis or treatment, please talk to your health care provider immediately regarding your specific medical needs. LPOXY Therapeutics does not give medical advice, nor do we provide medical or diagnostic services. If you have or suspect you have a medical problem or condition, contact a qualified health care professional.

LPOXY Therapeutics is developing SIDIPREV™ to be taken with antibiotics to prevent antibiotic-induced C. difficile colitis.

SIDIPREV™ is an orally-administered, metered-dose intestinal oxygen delivery therapeutic that gently raises colon oxygen levels.

For more information about our use and development of enteric aerobization therapy, contact us.